Results 11 to 20 of about 12,928,896 (364)

Abnormal Liver Function Tests in Patients With COVID‐19: Relevance and Potential Pathogenesis

open access: yesHepatology, 2020
Abnormal liver function tests (LFTs) are reported frequently in hospitalized coronavirus disease 2019 (COVID-19) patients. A review of the literature shows that 46% of admitted COVID-19 patients had elevated plasma aspartate aminotransferase (AST) and 35%
A. Bertolini   +10 more
semanticscholar   +1 more source

Abnormal liver function [PDF]

open access: yesGut, 2007
A 58-year-old man was found lying beside his motorcycle in February 2006. A brain CT scan was performed in the hospital because of unsteady gait and one-sided weakness. Left occipital intracranial haemorrhage and cerebellar infarction were diagnosed, …
Yang-Yuan Chen   +4 more
openaire   +3 more sources

Age-related changes in liver metabolism and antioxidant capacity of laying hens

open access: yesPoultry Science, 2021
: This study aimed to investigate the age-related changes of hepatic metabolism and antioxidant capacity of laying hens at 3 different ages. A total of 192 Hy-line Brown laying hens were assigned into 3 groups: 1) 195-day-old (D195 group); 2) 340-day-old
Y.F. Gu   +5 more
doaj   +1 more source

Abnormal liver function tests predict transfer to intensive care unit and death in COVID‐19

open access: yesLiver international (Print), 2020
The pandemic of coronavirus disease 2019 (COVID‐19) has emerged as a relevant threat for humans worldwide. Abnormality in liver function tests (LFTs) has been commonly observed in patients with COVID‐19, but there is controversy on its clinical ...
S. Piano   +14 more
semanticscholar   +1 more source

Abnormal liver function tests associated with severe rhabdomyolysis

open access: yesWorld Journal of Gastroenterology, 2020
Rhabdomyolysis is a syndrome of skeletal muscle injury with release of cellular constituents such as potassium, phosphate, urate and intracellular proteins such as myoglobin into the circulation, which may cause complications including acute kidney ...
A. Lim
semanticscholar   +1 more source

COVID-19 associated variations in liver function parameters: a retrospective study

open access: yesPostgraduate medical journal, 2020
Background Characteristics of laboratory findings of COVID-19 patients are of great significance for diagnosis and treatment. Studies that have analysed the variations in hepatic profile in correlation with the inflammatory markers in SARS-CoV-2 are ...
R. Saini   +9 more
semanticscholar   +1 more source

The Prevalence of Gastrointestinal Symptoms, Abnormal Liver Function, Digestive System Disease and Liver Disease in COVID-19 Infection

open access: yesJournal of Clinical Gastroenterology, 2020
Supplemental Digital Content is available in the text. Background: The worldwide outbreak of COVID-19 infected millions of people. Some patients had gastrointestinal (GI) symptoms, abnormal liver function, digestive system disease and liver disease. Aim:
Zi-yuan Dong   +4 more
semanticscholar   +1 more source

Serum sphingomyelin has potential to reflect hepatic injury in chronic hepatitis B virus infection

open access: yesInternational Journal of Infectious Diseases, 2015
Objective: To explore the relation between serum sphingolipids and hepatic injury in chronic HBV infection. Methods: A cohort of participants including 48 healthy persons, 103 chronic HBV-infected patients containing chronic hepatitis B (CHB) and HBV ...
Su-Jun Zheng   +9 more
doaj   +1 more source

Combined Treatment with Herbal Medicine and Drug Ameliorates Inflammation and Metabolic Abnormalities in the Liver of an Amyotrophic Lateral Sclerosis Mouse Model

open access: yesAntioxidants, 2022
To date, no effective drugs exist for amyotrophic lateral sclerosis (ALS), although riluzole (RZ) and edaravone have been approved for treatment. We previously reported that Bojungikgi-tang (BJIGT) improved motor activity through anti-inflammatory ...
Hee Ra Park, Eun Jin Yang
doaj   +1 more source

Liver function and prognosis, and influence of sacubitril/valsartan in patients with heart failure with reduced ejection fraction

open access: yesEuropean Journal of Heart Failure, 2020
The prevalence of liver function abnormalities is common in patients with heart failure (HF) with reduced ejection fraction (HFrEF). We assessed the impact of liver function on prognosis and the effect of sacubitril/valsartan on measures of liver ...
Kota Suzuki   +11 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy